Phosphotyrosine phosphatase and tyrosine kinase inhibition modulate airway pressure-induced lung injury.
We determined whether drugs which modulate the state of protein tyrosine phosphorylation could alter the threshold for high airway pressure-induced microvascular injury in isolated perfused rat lungs. Lungs were ventilated for successive 30-min periods with peak inflation pressures (PIP) of 7, 20, 30, and 35 cmH2O followed by measurement of the capillary filtration coefficient (Kfc), a sensitive index of hydraulic conductance. In untreated control lungs, Kfc increased by 1.3- and 3.3-fold relative to baseline (7 cmH2O PIP) after ventilation with 30 and 35 cmH2O PIP. However, in lungs treated with 100 microM phenylarsine oxide (a phosphotyrosine phosphatase inhibitor), Kfc increased by 4.7- and 16.4-fold relative to baseline at these PIP values. In lungs treated with 50 microM genistein (a tyrosine kinase inhibitor), Kfc increased significantly only at 35 cmH2O PIP, and the three groups were significantly different from each other. Thus phosphotyrosine phosphatase inhibition increased the susceptibility of rat lungs to high-PIP injury, and tyrosine kinase inhibition attenuated the injury relative to the high-PIP control lungs.
Parker
J C
JC
Department of Physiology, University of South Alabama, Mobile, Alabama 36688, USA. Jparker@jaguar1.usouthal.edu
Ivey
C L
CL
Tucker
A
A
D000399:Air Pressure; D000818:Animals; D001152:Arsenicals / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects / Q000502:physiology; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006452:Hemoglobinometry; D066298:In Vitro Techniques; D008168:Lung / Q000473:pathology / Q000503:physiopathology*; D055370:Lung Injury; D008297:Male; D017027:Protein Tyrosine Phosphatases / Q000037:antagonists & inhibitors*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D011652:Pulmonary Circulation / Q000187:drug effects / Q000502:physiology; D011669:Pulmonary Wedge Pressure / Q000502:physiology; D051381:Rats; D014655:Vascular Resistance / Q000187:drug effects / Q000502:physiology
D001152:Arsenicals; D004791:Enzyme Inhibitors; C029341:oxophenylarsine; D011505:Protein-Tyrosine Kinases; D017027:Protein Tyrosine Phosphatases